KLRS$2.10+4.99%
Kalaris Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$49.99M
Float & O/S:9.54M / 23.8M
Inst Own:75.7%
DilutionScan read 36 of Kalaris Therapeutics, Inc.'s SEC filings and found 1 warrant series, 6 convertibles, 1 ATM program, 2 shelf registrations and 1 completed offering on file for KLRS. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 7, 2026.
